Three-dimensional inkjet printing using polyamide-forming materials

Patent metadata

Field	Value
Publication number	US-12194673-B2
Application number	US-202117510468-A
Country	US
Kind code	B2
Filing date	Oct 26, 2021
Priority date	Feb 5, 2016
Publication date	Jan 14, 2025
Grant date	Jan 14, 2025

Abstract

Formulation systems usable for fabricating a three-dimensional object made of a polyamide-containing material, by three-dimensional 3D inkjet printing, and methods and systems utilizing same, are provided. The formulation systems are formed of at least a first and second model formulations containing a lactam and a catalyst for inducing anionic ring opening polymerization of the lactam in the first formulation, and an activator for promoting anionic ring opening polymerization of the lactam in the second formulation, and are further characterized as: including in the first and/or second formulation a compound capable of increasing a rate of said polymerization upon exposure to said curing energy; including as an activator a lactam-blocked polyisocyanate; and/or as including in the first model formulation at least one material capable of reducing a melting point of said first model formulation. Formulation systems usable at a selected ratio are also provided.

First claim

What is claimed is:

1. A two-part formulation system suitable for three-dimensional inkjet printing of an object comprising a polyamide material, the formulation system comprising:
a first formulation comprising a lactam and a catalyst for inducing anionic ring opening polymerization of said lactam; and
a second formulation comprising an activator for promoting said polymerization, said lactam and a lactone,
wherein at least one of said first and second formulations further comprises a compound capable of increasing a rate of said polymerization upon exposure to curing energy, said compound being an amine-containing compound,
wherein said activator is or comprises a lactam-blocked polyisocyanate material featuring three or more isocyanate groups,
and wherein said amine-containing compound is or comprises a polyalkylene imine that has a molecular weight lower than 5,000 grams/mol.

2. The formulation system of claim 1 , wherein said polyalkylene imine is a hyperbranched polyalkylene imine.

3. The formulation system of claim 1 , wherein said polyisocyanate is an isocyanurate trimer of a diisocyanate.

4. The formulation system of claim 1 , wherein said first formulation further comprises at least one material that reduces a melting point of said first formulation.

5. The formulation system of claim 4 , wherein a melting point of said first formulation is lower than 68° C., or lower than 65° C., or lower than 62° C., or lower than 60° C.

6. The formulation system of claim 1 , wherein said lactam is a caprolactam.

7. The formulation system of claim 1 , wherein said lactam is ε-caprolactam.

8. The formulation system of claim 1 , wherein said catalyst is a caprolactamate salt or is capable of generating said caprolactamate salt.

9. The formulation system of claim 1 , wherein said lactone is selected from the group consisting of 6-valerolactone, γ-butyrolactone, ε-caprolactone, ω-pentadecalactone, cyclopentadecanone, 16-hexadecanolide and oxacyclotridecan-2-one.

10. The formulation system of claim 1 , wherein said first formulation comprises said amine-containing compound and is devoid of said activator or is devoid of a lactone.

11. The formulation system of claim 1 , wherein said second formulation is devoid of said catalyst.

12. The formulation system of claim 1 , wherein a concentration of said lactam in said first formulation ranges from 10 to 99, % by weight of the total weight of the first formulation.

13. The formulation system of claim 1 , wherein a concentration of said lactam in said second formulation ranges from 10 to 90, % by weight of the total weight of the second formulation.

14. The formulation system of claim 1 , wherein a concentration of said activator in said second formulation ranges from 5 to 50, % by weight of the total weight of the second formulation.

15. The formulation system of claim 4 , wherein a concentration of said material selected for reducing a melting point of said first formulation ranges from 0.5 to 25% by weight of the total weight of the first formulation.

16. The formulation system of claim 1 , wherein a concentration of said lactam in said second formulation ranges from 10 to 50% by weight of the total weight of the second formulation, and a concentration of said activator ranges from 10 to 30% by weight of the total weight of the second formulation.

17. The formulation system of claim 1 , wherein said polyalkylene imine is a polyethylene imine.

Assignees

• Stratasys Ltd

Inventors

• Kuno Lev
• Yudovin-Farber Ira
• Damari Liora
• Matzner Eynat

Classifications

• C08L79/02

  Polyamines · CPC title

• C08L71/02

  Polyalkylene oxides · CPC title

• C08K5/29

  Compounds containing {one or more} carbon-to-nitrogen double bonds · CPC title

• C08G69/18

  Anionic polymerisation · CPC title

• B29C64/129

  characterised by the energy source therefor, e.g. by global irradiation combined with a mask · CPC title